Epigenomic silencing of the BMP-4 gene in pituitary adenomas: A potential target for Epidrug-induced re-expression

Endocrinology

Volumn 153, Issue 8, 2012, Pages 3603-3612

  Yacqub Usman, Kiren ^a   Duong, Cuong V ^a   Clayton, Richard N ^a   Farrell, William E ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; HISTONE; HISTONE H3; TRICHOSTATIN A; ZEBULARINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHROMATIN; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; HYPOPHYSIS ADENOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLACTINOMA; PROTEIN EXPRESSION; PROTEIN METHYLATION; RAT;

ANIMALS; BONE MORPHOGENETIC PROTEIN 4; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CPG ISLANDS; CYTIDINE; DNA METHYLATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIGENESIS, GENETIC; GENE SILENCING; HISTONES; HUMANS; MICE; PITUITARY NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84864392485     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1231     Document Type: Article

References (36)

1. Massagué J 1998 TGF-beta signal transduction. Annu Rev Biochem 67:753-791
2. Massagué J 2000 How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1:169-178
3. Kawabata M, Imamura T, Miyazono K 1998 Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 9:49-61 (Pubitemid 28280536)
4. Scully KM, Rosenfeld MG 2002 Pituitary development: regulatory codes in mammalian organogenesis. Science 295:2231-2235 (Pubitemid 34258830)
5. Rosenfeld MG, Briata P, Dasen J, Gleiberman AS, Kioussi C, Lin C, O'Connell SM, Ryan A, Szeto DP, Treier M 2000 Multistep signaling and transcriptional requirements for pituitary organogenesis in vivo. Recent Prog Horm Res 55:1-13; discussion 13-4
6. Paez-Pereda M, Giacomini D, Refojo D, Nagashima AC, Hopfner U, Grubler Y, Chervin A, Goldberg V, Goya R, Hentges ST, Low MJ, Holsboer F, Stalla GK, Arzt E 2003 Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. Proc Natl Acad Sci USA 100:1034-1039 (Pubitemid 36183950)
7. Giacomini D, Páez-Pereda M, Theodoropoulou M, Labeur M, Refojo D, Gerez J, Chervin A, Berner S, Losa M, Buchfelder M, Renner U, Stalla GK, Arzt E 2006 Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action. Endocrinology 147:247-256 (Pubitemid 43004278)
8. Giacomini D, Páez-Pereda M, Theodoropoulou M, Gerez J, Nagashima AC, Chervin A, Berner S, Labeur M, Refojo D, Renner U, Stalla GK, Arzt E 2006 Bone morphogenetic protein-4 control of pituitary pathophysiology. Front Horm Res 35:22-31 (Pubitemid 44024239)
9. Takeda M, Otsuka F, Suzuki J, Kishida M, Ogura T, Tamiya T, Makino H 2003 Involvement of activin/BMP system in development of human pituitary gonadotropinomas and nonfunctioning adenomas. Biochem Biophys Res Commun 306:812-818 (Pubitemid 36776203)
10. Bosch-Presegué L, Vaquero A 2011 The dual role of sirtuins in cancer. Genes Cancer 2:648-662
11. Wang P, Chen Z, Meng ZQ, Fan J, Luo JM, Liang W, Lin JH, Zhou ZH, Chen H, Wang K, Shen YH, Xu ZD, Liu LM 2009 Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasissuppressive function. Carcinogenesis 30:1497-1506
12. Pelosi G, Fumagalli C, Trubia M, Sonzogni A, Rekhtman N, Maisonneuve P, Galetta D, Spaggiari L, Veronesi G, Scarpa A, Malpeli G, Viale G 2010 Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung. Anticancer Res 30:4269-4281
13. Melmed S 2003 Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest 112:1603-1618 (Pubitemid 38063716)
14. Dudley KJ, Revill K, Clayton RN, Farrell WE 2009 Pituitary tumours: all silent on the epigenetics front. J Mol Endocrinol 42:461-468
15. Melmed S 2011 Pathogenesis of pituitary tumors. Nat Rev Endocrinol 7:257-266
16. Farrell WE 2005 Epigenetic mechanisms of tumorigenesis. Horm Metab Res 37:361-368 (Pubitemid 41008770)
17. Vandeva S, Jaffrain-Rea ML, Daly AF, Tichomirowa M, Zacharieva S, Beckers A 2010 The genetics of pituitary adenomas. Best Pract Res Clin Endocrinol Metab 24:461-476
18. Al-Azzawi H, Yacqub-Usman K, Richardson A, Hofland LJ, Clayton RN, Farrell WE 2011 Reversal of endogenous dopamine receptor silencing in pituitary cells augments receptor-mediated apoptosis. Endocrinology 152:364-373
19. Bahar A, Simpson DJ, Cutty SJ, Bicknell JE, Hoban PR, Holley S, Mourtada-Maarabouni M, Williams GT, Clayton RN, Farrell WE 2004 Isolation and characterization of a novel pituitary tumor apoptosis gene. Mol Endocrinol 18:1827-1839 (Pubitemid 38859588)
20. Bates AS, Farrell WE, Bicknell EJ, McNicol AM, Talbot AJ, Broome JC, Perrett CW, Thakker RV, Clayton RN 1997 Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J Clin Endocrinol Metab 82:818-824 (Pubitemid 27106594)
21. Revill K, Dudley KJ, Clayton RN, McNicol AM, Farrell WE 2009 Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma. Endocr Relat Cancer 16:537-548
22. Dudley KJ, Revill K, Whitby P, Clayton RN, Farrell WE 2008 Genome- wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors. Mol Cancer Res 6:1567-1574
23. Jenuwein T, Allis CD 2001 Translating the histone code. Science 293:1074-1080 (Pubitemid 32758077)
24. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, Jones RS, Zhang Y 2002 Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298:1039-1043 (Pubitemid 35247314)
25. Roh TY, Cuddapah S, Cui K, Zhao K 2006 The genomic landscape of histone modifications in human T cells. Proc Natl Acad Sci USA 103:15782-15787 (Pubitemid 44657544)
26. Walker JM 1994 The bicinchoninic acid (BCA) assay for protein quantitation. Methods Mol Biol 32:5-8
27. Schuff KG, Hentges ST, Kelly MA, Binart N, Kelly PA, Iuvone PM, Asa SL, Low MJ 2002 Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest 110:973-981
28. Asa SL, Kelly MA, Grandy DK, Low MJ 1999 Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology 140:5348-5355
29. Lidhar K, Korbonits M, Jordan S, Khalimova Z, Kaltsas G, Lu X, Clayton RN, Jenkins PJ, Monson JP, Besser GM, Lowe DG, Grossman AB 1999 Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. J Clin Endocrinol Metab 84:3823-3830 (Pubitemid 30645248)
30. Ezzat S 2008 Epigenetic control in pituitary tumors. Endocr J 55: 951-957
31. Ezzat S, Zhu X, Loeper S, Fischer S, Asa SL 2006 Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to up-regulate a survival signal in pituitary cells. Mol Endocrinol 20:2976-2986 (Pubitemid 44833549)
32. Zhu X, Mao X, Hurren R, Schimmer AD, Ezzat S, Asa SL 2008 Deoxyribonucleic acid methyltransferase 3B promotes epigenetic silencing through histone 3 chromatin modifications in pituitary cells. J Clin Endocrinol Metab 93:3610-3617
33. Otsuka F, Tsukamoto N, Miyoshi T, Iwasaki Y, Makino H 2012 BMP action in the pituitary: Its possible role in modulating somatostatin sensitivity in pituitary tumor cells. Mol Cell Endocrinol 349:105-110
34. Tsukamoto N, Otsuka F, Miyoshi T, Inagaki K, Nakamura E, Terasaka T, Takeda M, Ogura T, Iwasaki Y, Makino H 2011 Functional interaction of bone morphogenetic protein and growth hormone releasing peptide in adrenocorticotropin regulation by corticotrope cells. Mol Cell Endocrinol 344:41-50
35. Tsukamoto N, Otsuka F, Miyoshi T, Yamanaka R, Inagaki K, Yamashita M, Otani H, Takeda M, Suzuki J, Ogura T, Iwasaki Y, Makino H 2010 Effects of bone morphogenetic protein (BMP) on adrenocorticotropin production by pituitary corticotrope cells: involvement of up-regulation of BMP receptor signaling by somatostatin analogs. Endocrinology 151:1129-1141
36. Páez-Pereda M, Kovalovsky D, Hopfner U, Theodoropoulou M, Pagotto U, Uhl E, Losa M, Stalla J, Grübler Y, Missale C, Arzt E, Stalla GK 2001 Retinoic acid prevents experimental Cushing syndrome. J Clin Invest 108:1123-1131 (Pubitemid 32995370)